Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-04-24, Stock:ABBV, The news for the past five days is as follows:
2020-04-17: NEWS1: Form 8.3 - AbbVie Inc..NEWS2: FORM 8.3 - ABBVIE INC - Amendment.NEWS3: FORM 8.3 - ABBVIE PLC.NEWS4: AbbVie Stock Rises 3%.
2020-04-20: NEWS1: Stock Market Today With Jim Cramer: Oil Prices Go Negative.NEWS2: Johnson & Johnson's Diversified Business Serves It Well in Uncertain Times.NEWS3: AbbVie Analyst Upgrades Stock To Outperform, Looks Forward To 2021.NEWS4: Is AbbVie Stock A Buy Amid The Ongoing Coronavirus Pandemic?.NEWS5: AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes.NEWS6: Form 8.3 - AbbVie Inc..
2020-04-21: NEWS1: Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly.NEWS2: IMBRUVICA® (ibrutinib) Receives 11th FDA Approval.NEWS3: Allergan’s Acquisition by AbbVie Will Close Soon. Why One Analyst Just Downgraded Its Stock..NEWS4: 8 Safe High-Yield Dividend Stocks Offering 5% or More.NEWS5: Form 8.3 - ABBVIE PLC.NEWS6: AbbVie Stock Falls 3%.NEWS7: AbbVie- A Top Choice for a Post-Virus Portfolio.NEWS8: Form 8.3 - AbbVie Inc..
2020-04-22: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS2: Were Hedge Funds Right About AbbVie Inc (ABBV)?.NEWS3: Healthcare ETFs Looks Strong Ahead of Q1 Earnings.NEWS4: Form 8.3 - Abbvie Inc - Amendment.NEWS5: Form 8.3 - ABBVIE INC.NEWS6: AbbVie Gets FDA Nod for Imbruvica+Rituxan in First-Line CLL.NEWS7: Form 8.3 - AbbVie Inc..
2020-04-23: NEWS1: Form 8.3 - AbbVie Inc..NEWS2: FORM 8.3 - ABBVIE INC.

Answer: Rise